These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

1171 related items for PubMed ID: 20357664

  • 1. Escitalopram versus serotonin noradrenaline reuptake inhibitors as second step treatment for patients with major depressive disorder: a pooled analysis.
    Lam RW, Lönn SL, Despiégel N.
    Int Clin Psychopharmacol; 2010 Jul; 25(4):199-203. PubMed ID: 20357664
    [Abstract] [Full Text] [Related]

  • 2. Cost effectiveness of escitalopram versus SNRIs in second-step treatment of major depressive disorder in Sweden.
    Nordström G, Despiegel N, Marteau F, Danchenko N, Maman K.
    J Med Econ; 2010 Jul; 13(3):516-26. PubMed ID: 20698748
    [Abstract] [Full Text] [Related]

  • 3. Escitalopram versus SNRI antidepressants in the acute treatment of major depressive disorder: integrative analysis of four double-blind, randomized clinical trials.
    Kornstein SG, Li D, Mao Y, Larsson S, Andersen HF, Papakostas GI.
    CNS Spectr; 2009 Jun; 14(6):326-33. PubMed ID: 19668123
    [Abstract] [Full Text] [Related]

  • 4. Efficacy of escitalopram in the treatment of major depressive disorder compared with conventional selective serotonin reuptake inhibitors and venlafaxine XR: a meta-analysis.
    Kennedy SH, Andersen HF, Lam RW.
    J Psychiatry Neurosci; 2006 Mar; 31(2):122-31. PubMed ID: 16575428
    [Abstract] [Full Text] [Related]

  • 5. Remission of major depressive disorder without adverse events: a comparison of escitalopram versus serotonin norepinephrine reuptake inhibitors.
    Signorovitch J, Ramakrishnan K, Ben-Hamadi R, Yu AP, Wu EQ, Dworak H, Erder MH.
    Curr Med Res Opin; 2011 Jun; 27(6):1089-96. PubMed ID: 21438794
    [Abstract] [Full Text] [Related]

  • 6. Double-blind comparison of escitalopram and duloxetine in the acute treatment of major depressive disorder.
    Khan A, Bose A, Alexopoulos GS, Gommoll C, Li D, Gandhi C.
    Clin Drug Investig; 2007 Jun; 27(7):481-92. PubMed ID: 17563128
    [Abstract] [Full Text] [Related]

  • 7. Escitalopram and duloxetine in the treatment of major depressive disorder: a pooled analysis of two trials.
    Lam RW, Andersen HF, Wade AG.
    Int Clin Psychopharmacol; 2008 Jul; 23(4):181-7. PubMed ID: 18545055
    [Abstract] [Full Text] [Related]

  • 8. Escitalopram versus venlafaxine XR in the treatment of depression.
    Montgomery SA, Andersen HF.
    Int Clin Psychopharmacol; 2006 Sep; 21(5):297-309. PubMed ID: 16877901
    [Abstract] [Full Text] [Related]

  • 9. Escitalopram and duloxetine in major depressive disorder: a pharmacoeconomic comparison using UK cost data.
    Wade AG, Fernández JL, François C, Hansen K, Danchenko N, Despiegel N.
    Pharmacoeconomics; 2008 Sep; 26(11):969-81. PubMed ID: 18850765
    [Abstract] [Full Text] [Related]

  • 10. Duloxetine versus escitalopram and placebo in the treatment of patients with major depressive disorder: onset of antidepressant action, a non-inferiority study.
    Nierenberg AA, Greist JH, Mallinckrodt CH, Prakash A, Sambunaris A, Tollefson GD, Wohlreich MM.
    Curr Med Res Opin; 2007 Feb; 23(2):401-16. PubMed ID: 17288694
    [Abstract] [Full Text] [Related]

  • 11. Biological perspectives. Serotonin and norepinephrine reuptake inhibitors (SNRIs): venlafaxine and duloxetine.
    Lee SI, Keltner NL.
    Perspect Psychiatr Care; 2006 May; 42(2):144-8. PubMed ID: 16677140
    [No Abstract] [Full Text] [Related]

  • 12. Escitalopram in the treatment of major depressive disorder: a meta-analysis.
    Kennedy SH, Andersen HF, Thase ME.
    Curr Med Res Opin; 2009 Jan; 25(1):161-75. PubMed ID: 19210149
    [Abstract] [Full Text] [Related]

  • 13. Vortioxetine for major depressive disorder: An indirect comparison with duloxetine, escitalopram, levomilnacipran, sertraline, venlafaxine, and vilazodone, using number needed to treat, number needed to harm, and likelihood to be helped or harmed.
    Citrome L.
    J Affect Disord; 2016 May 15; 196():225-33. PubMed ID: 26938965
    [Abstract] [Full Text] [Related]

  • 14. A double-blind comparison of escitalopram and venlafaxine extended release in the treatment of major depressive disorder.
    Bielski RJ, Ventura D, Chang CC.
    J Clin Psychiatry; 2004 Sep 15; 65(9):1190-6. PubMed ID: 15367045
    [Abstract] [Full Text] [Related]

  • 15. Effect of Vortioxetine vs. Escitalopram on Sexual Functioning in Adults with Well-Treated Major Depressive Disorder Experiencing SSRI-Induced Sexual Dysfunction.
    Jacobsen PL, Mahableshwarkar AR, Chen Y, Chrones L, Clayton AH.
    J Sex Med; 2015 Oct 15; 12(10):2036-48. PubMed ID: 26331383
    [Abstract] [Full Text] [Related]

  • 16. [Milnacipran and venlafaxine at flexible doses (up to 200 mg/d) in the outpatient treatment of adults with moderate-to-severe major depressive disorder: a 24-week randomised, double blind exploratory study].
    Olié JP, Gourion D, Montagne A, Rostin M, Poirier MF.
    Encephale; 2009 Dec 15; 35(6):595-604. PubMed ID: 20004291
    [Abstract] [Full Text] [Related]

  • 17. [Serotonin-noradrenaline reuptake inhibitors(SNRIs)].
    Ishigooka J.
    Nihon Rinsho; 2001 Aug 15; 59(8):1523-9. PubMed ID: 11519152
    [Abstract] [Full Text] [Related]

  • 18. Changes in sexual functioning associated with duloxetine, escitalopram, and placebo in the treatment of patients with major depressive disorder.
    Clayton A, Kornstein S, Prakash A, Mallinckrodt C, Wohlreich M.
    J Sex Med; 2007 Jul 15; 4(4 Pt 1):917-29. PubMed ID: 17627739
    [Abstract] [Full Text] [Related]

  • 19. Duloxetine versus other anti-depressive agents for depression.
    Cipriani A, Koesters M, Furukawa TA, Nosè M, Purgato M, Omori IM, Trespidi C, Barbui C.
    Cochrane Database Syst Rev; 2012 Oct 17; 10():CD006533. PubMed ID: 23076926
    [Abstract] [Full Text] [Related]

  • 20. Escitalopram in the treatment of major depressive disorder: clinical efficacy, tolerability and cost-effectiveness vs. venlafaxine extended-release formulation.
    Llorca PM, Fernandez JL.
    Int J Clin Pract; 2007 Apr 17; 61(4):702-10. PubMed ID: 17394446
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 59.